Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies
Barry A SchechterCornea and Cataract Service, Florida Eye Microsurgical Institute, Boynton Beach, FL, USAAbstract: Topical ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat postoperative inflammation and pain following cataract surgery and for treatment and prophyla...
Saved in:
Main Author: | Schechter BA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/c99162c1e0de4c70bfd03d76bcb45647 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population
by: Palacio C, et al.
Published: (2016) -
Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
by: Sheppard JD
Published: (2016) -
Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery
by: Kim T, et al.
Published: (2018) -
A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
by: Hosseini K, et al.
Published: (2016) -
Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy
by: Brooks CC, et al.
Published: (2020)